Charles River Laboratory Joins Chicago Technology Park.

CHICAGO -- The Chicago Technology Park, Inc. (CTP), serving as a vital ground for start-up and developing technology companies, announced today that the Charles River Laboratories has opened a new pathology facility within the 56-acre technology park. Charles River becomes the ninth contract research organization (CRO) to locate within the CTP.

Based in Wilmington, Mass., Charles River is a global provider of solutions that advance the drug discovery and development process. The company supplies research models and laboratory animal support services, preclinical services, and clinical services to the biomedical market.

Charles River's new CTP pathology facility will provide biopharmaceutical product and process services, including pathology-based expertise required for regulatory studies and investigative research to support non-clinical product development programs.

"Charles River's decision to locate one of its research facilities to the CTP is a testament to our resources, facilities and people," said Samuel Pruett, CTP Executive Director. "As the outsourcing trend in pharmaceutical discovery and development continues, we want other CROs and life-science companies to know the CTP is an attractive destination to grow their business."

For more information on the CTP or other CTP companies, visit www.techpark.com.

About The Chicago Technology Park

The Chicago Technology Park is a 56-acre research park that fosters the commercialization of innovative technologies through state-of-the-art facilities and critical support services. The CTP is administered by the Illinois Medical District in partnership with the University Of Illinois and Rush University Medical Center. The CTP Research Center was one of the first biotechnology incubators in the U.S. and is still one of the largest. The CTP is currently home to 30 early- and mid-stage technology-driven companies. For more information visit www.techpark.com.